MARKET

IRIX

IRIX

Iridex
NASDAQ
0.9803
+0.0307
+3.23%
Closed 16:00 04/02 EDT
OPEN
0.9500
PREV CLOSE
0.9496
HIGH
1.020
LOW
0.9500
VOLUME
60.58K
TURNOVER
--
52 WEEK HIGH
1.648
52 WEEK LOW
0.7900
MARKET CAP
16.85M
P/E (TTM)
-3.7416
1D
5D
1M
3M
1Y
5Y
1D
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth
NASDAQ · 2d ago
Weekly Report: what happened at IRIX last week (0323-0327)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 03/27 17:05
Iridex price target lowered to $2.75 from $3 at Alliance Global
TipRanks · 03/27 12:55
Iridex Earnings Call Signals Turnaround Amid Margin Strain
TipRanks · 03/27 00:17
Iridex outlines $51M-$53M 2026 revenue target as manufacturing shift and cost cuts drive positive cash flow
Seeking Alpha · 03/26 22:57
IRIDEX GAAP EPS of -$0.01 beats by $0.01, revenue of $14.7M misses by $0.04M
Seeking Alpha · 03/26 20:18
Iridex Q4 revenue rises on higher retina system sales
Reuters · 03/26 20:17
More
About IRIX
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Webull offers IRIDEX Corp stock information, including NASDAQ: IRIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRIX stock methods without spending real money on the virtual paper trading platform.